Senate Strips Pay-For-Delay Ban From Spending Bill

Law360, New York (July 23, 2010, 3:30 PM EDT) -- The U.S. Senate has abandoned an amendment sent to it by the House of Representatives that would have limited pharmaceutical companies' ability to enter into legal agreements to delay the market introduction of generic drugs.

Senators failed to muster the 60 votes needed to close debate on a package of amendments to H.R. 4899, the Emergency Supplemental Appropriations Act, on Thursday night. Following a failed 46-51 vote to reach cloture, the Senate unanimously consented to send the original appropriations bill back to the House without the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.